Wilson Sonsini is pleased to present the latest edition of The Life Sciences Report. This issue features an article on interlocking boards in the life sciences sector and the antitrust risk they pose to firms and investors; an interview with Civilization Ventures founder and general partner Shahram Seyedin-Noor conducted by Matthew Meyer, the firm’s Chief Business Advisor for Life Sciences; a piece on life sciences venture financings in which firm clients participated across the second half of 2021 and the first half of 2022; and articles on the FDA’s digital health policy for clinical decision software functions and the FDA’s first pre-market consultation for lab-grown meat using animal cell culture technology. In addition, the publication includes details on the recent launch of a life sciences representative term sheet, an article on Jon Soderstrom joining the firm as chief licensing advisor, and recaps of several recent Wilson Sonsini events—including the 27thAnnual Phoenix Conference, Women in Biotech Fall Mixer, Life Sciences Investment Forum, and Japan Trade Mission and Roadshow for Healthcare Companies—along with select recent life sciences client highlights and upcoming programs, including the firm’s inaugural 1L Life Sciences Summit.